Clinical Trial Update: GIST: Assessment of Tumor Mutations and TKI Plasma Exposure

View source ↗

Summary

A completed clinical trial update examining tumor mutation profiles and the plasma exposure of tyrosine kinase inhibitors in gastrointestinal stromal tumor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Stromal Tumor

Snippet

Sponsor: University Medical Center Groningen | Conditions: Gastro-intestinal Stromal Tumor | Status: COMPLETED